354824-09-2 Usage
Uses
Used in Pharmaceutical Industry:
3-(Aminomethyl)-N,N-dimethyl-2-pyridinamine is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and medicines.
Used in Agrochemical Industry:
In the agrochemical sector, DMAPA is utilized as a precursor in the production of agrochemicals, which are essential for enhancing crop protection and yield.
Used in Dye Industry:
3-(Aminomethyl)-N,N-dimethyl-2-pyridinamine is employed as a component in the manufacturing process of dyes, playing a role in the creation of a diverse range of colorants for various applications.
Used in Rubber Chemicals Production:
DMAPA is used as a reactant in the production of rubber chemicals, which are crucial for improving the performance and properties of rubber products.
Used in Surfactant Industry:
3-(Aminomethyl)-N,N-dimethyl-2-pyridinamine is utilized as a component in the synthesis of surfactants, which are essential in a variety of consumer products and industrial applications for their ability to reduce surface tension.
Used in Corrosion Inhibitors:
3-(Aminomethyl)-N,N-dimethyl-2-pyridinamine is used in the formulation of corrosion inhibitors, helping to protect materials from degradation and extending their service life.
It is important to handle DMAPA with care due to its potential health hazards, such as causing irritation to the skin, eyes, and respiratory system, as well as its flammability and toxicity when ingested or inhaled.
Check Digit Verification of cas no
The CAS Registry Mumber 354824-09-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,4,8,2 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 354824-09:
(8*3)+(7*5)+(6*4)+(5*8)+(4*2)+(3*4)+(2*0)+(1*9)=152
152 % 10 = 2
So 354824-09-2 is a valid CAS Registry Number.
354824-09-2Relevant academic research and scientific papers
Fused imidazolium derivatives
-
, (2008/06/13)
This invention relates to medicaments, particularly novel fused imidazolium derivatives useful for the treatment of cancers and novel synthetic intermediate compounds thereof. The novel imidazolium derivatives fused with an aryl or heteroaryl ring, characterized in that the 1- and/or 3-position is substituted by an alkyl group etc. having a substituent selected from the group consisting of —ORa, —SRa and the like, have excellent anti-tumor activity and low toxicity and are useful as anticancer agents having wide margins of safety.
